ResearcherNanjing Drum Tower HospitalActive in the last 2 years

Yu Xie

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0002-8837-1465; OpenAlex author ID A5158362717. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

HMGA2 Stabilizes hnRNPK to Drive YAP-Dependent Liver Metastasis in Pancreatic Cancer. Co-author DOI 10.7150/ijbs.133139 ↗
DHCR7 Promotes Liver Metastasis of Pancreatic Cancer Through PI3K-Akt Signaling Pathway. Co-author DOI 10.1111/cas.70185 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hao Cheng · 1 shared paper, 2026 · strength 0.30
- Paper HMGA2 Stabilizes hnRNPK to Drive YAP-Dependent Liver Metastasis in Pancreatic Cancer. DOI 10.7150/ijbs.133139 ↗
Hexing Hang · 1 shared paper, 2026 · strength 0.30
- Paper HMGA2 Stabilizes hnRNPK to Drive YAP-Dependent Liver Metastasis in Pancreatic Cancer. DOI 10.7150/ijbs.133139 ↗
Yudong Qiu · 1 shared paper, 2025 · strength 0.27
- Paper DHCR7 Promotes Liver Metastasis of Pancreatic Cancer Through PI3K-Akt Signaling Pathway. DOI 10.1111/cas.70185 ↗
Hao Cheng · 1 shared paper, 2025 · strength 0.27
- Paper DHCR7 Promotes Liver Metastasis of Pancreatic Cancer Through PI3K-Akt Signaling Pathway. DOI 10.1111/cas.70185 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.